Crossmark

Predictive value of C-reactive protein in patients treated with sunitinib for metastatic clear cell renal cell carcinoma

Crossref DOI link: https://doi.org/10.1186/s12894-017-0267-6

Published Online: 2017-08-31

Published Print: 2017-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Pilskog, Martin

Beisland, Christian

Akslen, Lars A.

Bostad, Leif

Haug, Åse

Heinrich, Daniel

Hjelle, Karin M.

Straume, Oddbjørn http://orcid.org/0000-0001-8867-3645
Funding

Funding for this research was provided by:

Norges Forskningsråd (223250)

The Norwegian Cancer Society

Pfizer Norway